(Q37111301)

18 August 2017

1 reference

title

CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model (English)

1 reference

18 August 2017

0 references

1 reference

cytomegaloviral disease

1 reference

1 reference

1

Rafaela Holtappels

1 reference

18 August 2017

4

Matthias J Reddehase

1 reference

18 August 2017

Verena Böhm

2

1 reference

18 August 2017

Jürgen Podlech

series ordinal

3

1 reference

18 August 2017

publication date

15 March 2008

1 reference

Medical Microbiology and Immunology

18 August 2017

published in

1 reference

18 August 2017

volume

197

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

125-134

1 reference

Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-008-0093-2

OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-008-0093-2

Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-008-0093-2

The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-008-0093-2

Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-008-0093-2

Adoptive CD8 T cell control of pathogens cannot be improved by combining protective epitope specificities

21 January 2018

1 reference

12 December 2020

Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence

1 reference

12 December 2020

Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus

1 reference

12 December 2020

Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)

1 reference

12 December 2020

Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.

1 reference

12 December 2020

CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation

1 reference

12 December 2020

Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype

1 reference

12 December 2020

DNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.

1 reference

12 December 2020

Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells

1 reference

12 December 2020

Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors.

1 reference

12 December 2020

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity

1 reference

12 December 2020

Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection

1 reference

12 December 2020

Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting

1 reference

12 December 2020

Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus

1 reference

12 December 2020

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

1 reference

12 December 2020

Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance

1 reference

12 December 2020

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

1 reference

12 December 2020

DNA immunization confers protection against murine cytomegalovirus infection

1 reference

12 December 2020

Coordinated Function of Murine Cytomegalovirus Genes Completely Inhibits CTL Lysis

1 reference

12 December 2020

Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues

1 reference

12 December 2020

Clinical aspects of CMV infection after stem cell transplantation

1 reference

12 December 2020

Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option?

1 reference

12 December 2020

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

1 reference

12 December 2020

Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.

1 reference

12 December 2020

Murine model of cytomegalovirus latency and reactivation.

1 reference

12 December 2020

In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection

1 reference

12 December 2020

Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation

1 reference

12 December 2020

Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs

1 reference

12 December 2020

Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge

1 reference

12 December 2020

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates

1 reference

12 December 2020

Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection

1 reference

12 December 2020

Role of T lymphocytes in recovery from murine cytomegalovirus infection

1 reference

12 December 2020

Role of murine cytomegalovirus US22 gene family members in replication in macrophages

1 reference

12 December 2020

The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells

1 reference

12 December 2020

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

1 reference

12 December 2020

Haematopoietic cell transplantation as immunotherapy

1 reference

12 December 2020

Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection

1 reference

12 December 2020

Principles for adoptive T cell therapy of human viral diseases

1 reference

12 December 2020

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

1 reference

12 December 2020

Cytomegalovirus encodes a positive regulator of antigen presentation

1 reference

12 December 2020

Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication

1 reference

12 December 2020

Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro

1 reference

12 December 2020

Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene

1 reference

12 December 2020

Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo

1 reference

12 December 2020

Cellular immunotherapy for viral infection after HSC transplantation

1 reference

12 December 2020

Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes

1 reference

12 December 2020

Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host

1 reference

12 December 2020

Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs

1 reference

12 December 2020

Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

1 reference

12 December 2020

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

12 December 2020

Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization

1 reference

12 December 2020

10.1007/S00430-008-0093-2

Identifiers

DOI

1 reference

release_hjiqhb5auvdrndli3a4bcfwx5y

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hjiqhb5auvdrndli3a4bcfwx5y

24 November 2022

mapped directly with Wikidata item

1 reference